279 related articles for article (PubMed ID: 2941574)
21. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
[TBL] [Abstract][Full Text] [Related]
22. Immunohistological analysis of skin reaction to My1 derived from Mycobacterium leprae.
Narayanan RB; Ramu G; Malaviya GN; Sinha S; Sengupta U
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):46-51. PubMed ID: 3519804
[TBL] [Abstract][Full Text] [Related]
23. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
24. Langerhans' cells in hair follicles of the depigmenting C57Bl/Ler-vit.vit mouse. A model for human vitiligo.
Palkowski MR; Nordlund ML; Rheins LA; Nordlund JJ
Arch Dermatol; 1987 Aug; 123(8):1022-8. PubMed ID: 2443080
[TBL] [Abstract][Full Text] [Related]
25. Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ.
Bos JD; Huisman PM; Krieg SR; Faber WR
Acta Derm Venereol; 1985; 65(2):132-7. PubMed ID: 2408415
[TBL] [Abstract][Full Text] [Related]
26. Immunological markers of Langerhans' cells in mycosis fungoides skin lesions.
Tjernlund U
Acta Derm Venereol; 1982; 62(3):241-3. PubMed ID: 6179366
[TBL] [Abstract][Full Text] [Related]
27. Variations in the number and morphology of Langerhans' cells in the epidermal component of squamous cell carcinomas.
Alcalay J; Goldberg LH; Wolf JE; Kripke ML
Arch Dermatol; 1989 Jul; 125(7):917-20. PubMed ID: 2742388
[TBL] [Abstract][Full Text] [Related]
28. Parasitism of antigen presenting cells in hyperbacillary leprosy.
Poulter LW; Collings LA; Tung KS; Waters MF
Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
[TBL] [Abstract][Full Text] [Related]
29. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
[TBL] [Abstract][Full Text] [Related]
30. Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.
Girolomoni G; Valle MT; Zacchi V; Costa MG; Giannetti A; Manca F
Immunology; 1996 Feb; 87(2):310-6. PubMed ID: 8698396
[TBL] [Abstract][Full Text] [Related]
31. HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus.
Caligaris-Cappio F; Bergui L; Tesio L; Ziano R; Camussi G
Clin Exp Immunol; 1985 Jan; 59(1):185-9. PubMed ID: 3156013
[TBL] [Abstract][Full Text] [Related]
32. Immunocompetent cells of fixed drug eruption.
Visa K; Käyhkö K; Stubb S; Reitamo S
Acta Derm Venereol; 1987; 67(1):30-5. PubMed ID: 2436411
[TBL] [Abstract][Full Text] [Related]
33. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
34. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
[TBL] [Abstract][Full Text] [Related]
35. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.
Baker BS; Swain AF; Griffiths CE; Leonard JN; Fry L; Valdimarsson H
Clin Exp Immunol; 1985 Sep; 61(3):526-34. PubMed ID: 3878241
[TBL] [Abstract][Full Text] [Related]
36. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
Aichinger G; Fill H; Wick G
Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
[TBL] [Abstract][Full Text] [Related]
37. HLA-DR-antigen bearing keratinocytes in various dermatologic disorders.
Smolle J
Acta Derm Venereol; 1985; 65(1):9-13. PubMed ID: 2578718
[TBL] [Abstract][Full Text] [Related]
38. T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).
Barnett AJ; Tait BD; Barnett MA; Toh BH
Clin Exp Immunol; 1989 Apr; 76(1):24-9. PubMed ID: 2525437
[TBL] [Abstract][Full Text] [Related]
39. Quantitative and morphologic changes of Langerhans' cells after ultraviolet A irradiation of human epidermis.
Liu HN; Muller SA; Schroeter AL
Acta Derm Venereol; 1987; 67(5):411-6. PubMed ID: 2448992
[TBL] [Abstract][Full Text] [Related]
40. Local involvement of antigen-presenting cells and activated T cells in perilesional and clinically uninvolved skin in pemphigus vulgaris.
Mashkilleyson N; Konttinen YT; Visa K
Acta Derm Venereol; 1989; 69(5):424-8. PubMed ID: 2572110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
